| Schedule of Disaggregated Revenue by Product And Services |
The
following table provides information about disaggregated revenue by product and services:
Schedule
of Disaggregated Revenue by Product And Services
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| | |
Three Months Ended September 30, | | |
Nine Months Ended September 30, | |
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| Product sales, net | |
$ | 3,393 | | |
$ | 1,684 | | |
$ | 26,199 | | |
$ | 3,633 | |
| Services | |
| 1,292 | | |
| 1,427 | | |
| 3,857 | | |
| 4,062 | |
| License, royalty and other | |
| 4,611 | | |
| 675 | | |
| 6,032 | | |
| 2,964 | |
| Total net revenues | |
$ | 9,296 | | |
$ | 3,786 | | |
$ | 36,088 | | |
$ | 10,659 | |
|
The
following table provides information about disaggregated revenue by product and services:
Schedule
of Disaggregated Revenue by Product And Services
| | |
2023 | | |
2022 | |
| | |
Year Ended December 31, | |
| | |
2023 | | |
2022 | |
| Product sales and rentals | |
$ | 13,149 | | |
$ | 3,749 | |
| Services | |
| 5,441 | | |
| 5,512 | |
| License, royalty and other | |
| 4,181 | | |
| 8,714 | |
| Net revenues | |
$ | 22,771 | | |
$ | 17,975 | |
|
| Schedule of Changes in Deferred Revenue from Contract Liabilities |
The
following table provides changes in deferred revenue from contract liabilities:
Schedule of Changes in Deferred Revenue from Contract Liabilities
| | |
2024 | | |
2023 | |
| Balance at January 1 | |
$ | 6,020 | | |
$ | 4,492 | |
| Beginning Balance | |
$ | 6,020 | | |
$ | 4,492 | |
| Deferral of revenue(1) | |
| 3,931 | | |
| 4,579 | |
| Recognition of unearned revenue(2) | |
| (3,619 | ) | |
| (3,514 | ) |
| Balance at September 30 | |
$ | 6,332 | | |
$ | 5,557 | |
| Ending Balance | |
$ | 6,332 | | |
$ | 5,557 | |
| (1) |
Deferral of revenue includes
$3,736 and $3,818 in 2024 and 2023, respectively, resulting from payments received in advance of performance under the biobanking services
storage contracts that are recognized as revenue under the contract as performance is completed. |
| (2) |
Recognition of unearned revenue
includes $2,271 and $2,274 that was included in the beginning deferred revenue balance at January 1, 2024 and 2023, respectively. |
|
The
following table provides changes in deferred revenue from contract liabilities:
Schedule of Changes in Deferred Revenue from Contract Liabilities
| | |
2023 | | |
2022 | |
| Balance at January 1 | |
$ | 4,492 | | |
$ | 4,067 | |
| Deferral of revenue* | |
| 6,266 | | |
| 5,004 | |
| Recognition of unearned revenue | |
| (4,738 | ) | |
| (4,579 | ) |
| Balance at December 31 | |
$ | 6,020 | | |
$ | 4,492 | |
| * | Deferral of revenue
resulted from payments received in advance of performance under the biobanking services storage contracts that are recognized as revenue
under the contract as performance is completed. Also includes up-front payment incurred in connection with signing of the Regeneron Services
Agreement in August 2023 (see Note 15 below). |
|